MedTrace Logo

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

NCT05361603 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2022-05-04

No results posted yet for this study

Summary

The principle is to propose dedicated monthly screening days bringing together the health personnel involved (hepatologist, addictologist, nurse in charge of the program, addictology nurse and social worker) and to propose appropriate management for each situation assessed.

Conditions

  • Hepatitis C
  • Transmission, Intravenous Drug Abuser
  • Addiction, Alcohol
  • Addiction Opiate
  • Hepatitis C Virus Infection, Response to Therapy of

Sponsors & Collaborators

  • University Hospital, Limoges

    lead OTHER

Principal Investigators

  • Marilyne DEBETTE-GRATIEN, MD · Hôpital Dupuytren

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-24
Primary Completion
2022-12-09
Completion
2030-02-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05361603 on ClinicalTrials.gov